Literature DB >> 1825180

Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation.

E M Cramer1, H Lu, J P Caen, C Soria, M C Berndt, D Tenza.   

Abstract

The subcellular localization of the platelet membrane receptors glycoproteins (GP) Ib and IIb/IIIa [corrected] has been studied within resting platelets by a combination of biochemical and cytochemical techniques. While both GPIb and GPIIb/IIIa are localized within the plasma membrane and surface-connected canalicular system (SCCS) membranes, only GPIIb/IIIa is present within the internal face of alpha-granular membranes. Previous studies demonstrated that plasmin can induce platelet stimulation and also decrease ristocetin-induced platelet aggregation; it was suggested that this was because of GPIb degradation by plasmin. In this study, the respective localizations of both GPIb and GPIIb/IIIa were visualized during in vitro plasmin stimulation of platelets. Generally, plasmin induced shape change, pseudopod formation, organelle centralization either with or without alpha-granule release depending on the conditions of stimulation. Plasmin treatment of platelets at 37 degrees C resulted in the disappearance of GPIb from the cell surface and its subsequent redistribution into the channels and vesicles of the SCCS with no significant modification of GPIIb/IIIa remaining on the plasma membrane. Within degranulated platelets, GPIIb/IIIa was expressed on the plasma membrane and within membranes of large vacuoles containing the alpha-granule proteins. GPIb was virtually absent from these structures and mainly restricted to the SCCS. Addition of cytochalasin D inhibited the migration of GPIb to the SCCS. Biochemical measurements confirmed that no important hydrolysis of GPIb had occurred because only very little amounts of glycocalicin were generated during the reaction. In conclusion, in plasmin-treated platelets GPIIb/IIIa is externalized to the plasma membrane while GPIb is internalized into the SCCS. Although previous studies have suggested that plasmin degrades GPIb, the reduction in ristocetin-induced aggregation may be explained by its apparent redistribution within the membranes of the SCCS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825180

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Glycoprotein Ib is homogeneously distributed on external and internal membranes of resting platelets.

Authors:  J G White; M D Krumwiede; G Escolar
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.

Authors:  N Kieffer; J Guichard; J Breton-Gorius
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

Review 3.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

4.  Effect of thrombin on maturing human megakaryocytes.

Authors:  E M Cramer; J M Massé; J P Caen; I Garcia; J Breton-Gorius; N Debili; W Vainchenker
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

5.  Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Authors:  Donna S Woulfe; Joanne Klimas Lilliendahl; Shelley August; Lubica Rauova; M Anna Kowalska; Magnus Abrink; Gunnar Pejler; James G White; Barbara P Schick
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

6.  Neutrophil proteinase cathepsin G is proteolytically active on the human platelet glycoprotein Ib-IX receptor: characterization of the cleavage sites within the glycoprotein Ib alpha subunit.

Authors:  D Pidard; P Renesto; M C Berndt; S Rabhi; K J Clemetson; M Chignard
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

Review 7.  Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.

Authors:  Masahiro Ide; Daniel Bolliger; Taro Taketomi; Kenichi A Tanaka
Journal:  J Anesth       Date:  2009-12-29       Impact factor: 2.078

8.  Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D I Simon; Z Chen; H Xu; C Q Li; J f Dong; L V McIntire; C M Ballantyne; L Zhang; M I Furman; M C Berndt; J A López
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases.

Authors:  Claudia Pielsticker; Martin F Brodde; Lisa Raum; Kerstin Jurk; Beate E Kehrel
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

10.  Activation-induced changes in platelet surface receptor expression and the contribution of the large-platelet subpopulation to activation.

Authors:  Masaaki Moroi; Richard W Farndale; Stephanie M Jung
Journal:  Res Pract Thromb Haemost       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.